First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
MIAMI--(BUSINESS WIRE)--Jun 1, 2024--
Source: joplinglobe.com
Study Investigator News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Study Investigator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Study Investigator Today - Breaking & Trending Today
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™
Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001) through six months, with...
Source: globenewswire.com
U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum
ZELSUVMI™ is expected to be commercially available during the second half of 2024 ...
Source: marketscreener.com
Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center, Melbourne, Australia
Initial Discussion Held with Clinical Investigator at Australia’s Biggest Cancer Hospital
Source: ibtimes.com.au
SELLAS Announces Confirmatory Top-Line Data Showing Survival and Clinical Benefits Based on the Final Analysis of the Phase 1/2 Clinical Trial of Galinpepimut-S in Combination with Keytruda® (pembrolizumab) in Patients with WT1+ Platinum-Resistant Advanced Ovarian Cancer
- Median Overall Survival for GPS Combination was 18.4 Months Compared to 13.8 months in a Checkpoint Inhibitor Single Agent Study in a Similar Patient Population Treated with Checkpoint Inhibitor... | November 10, 2022
Source: marketscreener.com